2000
A high number of tumor free axillary lymph nodes from patients with lymph node negative breast carcinoma is associated with poor outcome
Camp R, Rimm E, Rimm D. A high number of tumor free axillary lymph nodes from patients with lymph node negative breast carcinoma is associated with poor outcome. Cancer 2000, 88: 108-113. PMID: 10618612, DOI: 10.1002/(sici)1097-0142(20000101)88:1<108::aid-cncr15>3.0.co;2-b.Peer-Reviewed Original ResearchConceptsTumor-free lymph nodesLymph node negative breast carcinomaNode-negative breast carcinomaNegative breast carcinomaFree lymph nodesLymph nodesBreast carcinomaPrognostic valueTumor-free axillary lymph nodesTumor-negative lymph nodesDetectable lymph nodesNegative lymph nodesAxillary lymph nodesLymph node hyperplasiaLymph node metastasisReliable prognostic indicatorPresence of necrosisAxillary resectionLymphovascular invasionMetastatic diseasePatient ageIndependent predictorsLymphocytic infiltrateNode metastasisAggressive disease
1999
Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma
Camp R, Rimm E, Rimm D. Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma. Cancer 1999, 86: 2259-2265. PMID: 10590366, DOI: 10.1002/(sici)1097-0142(19991201)86:11<2259::aid-cncr13>3.0.co;2-2.Peer-Reviewed Original ResearchConceptsAxillary lymph node negative breast carcinomaLymph node negative breast carcinomaExpression of METNode-negative breast carcinomaNegative breast carcinomaBreast carcinomaMET expressionMetastatic diseaseRelative riskNegative invasive ductal carcinomaLow Met expressionMET-negative patientsIndependent predictive valueIndependent prognostic markerUseful prognostic indicatorInvasive ductal carcinomaStandard immunoperoxidase techniqueHigh MET expressionHepatocyte growth factorActivation of METAxillary lymphNegative patientsPatient agePrognostic factorsAggressive disease